GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Wuhan Keqian Biology Co Ltd (SHSE:688526) » Definitions » Days Sales Outstanding

Wuhan Keqian Biology Co (SHSE:688526) Days Sales Outstanding : 143.33 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Wuhan Keqian Biology Co Days Sales Outstanding?

Wuhan Keqian Biology Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥321.9 Mil. Wuhan Keqian Biology Co's Revenue for the three months ended in Mar. 2024 was ¥204.9 Mil. Hence, Wuhan Keqian Biology Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 143.33.

The historical rank and industry rank for Wuhan Keqian Biology Co's Days Sales Outstanding or its related term are showing as below:

SHSE:688526' s Days Sales Outstanding Range Over the Past 10 Years
Min: 27.36   Med: 57.71   Max: 129.24
Current: 129.24

During the past 8 years, Wuhan Keqian Biology Co's highest Days Sales Outstanding was 129.24. The lowest was 27.36. And the median was 57.71.

SHSE:688526's Days Sales Outstanding is ranked worse than
75.14% of 881 companies
in the Biotechnology industry
Industry Median: 72.67 vs SHSE:688526: 129.24

Wuhan Keqian Biology Co's Days Sales Outstanding increased from Mar. 2023 (108.54) to Mar. 2024 (143.33).


Wuhan Keqian Biology Co Days Sales Outstanding Historical Data

The historical data trend for Wuhan Keqian Biology Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Keqian Biology Co Days Sales Outstanding Chart

Wuhan Keqian Biology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial 63.14 52.28 69.61 107.82 112.36

Wuhan Keqian Biology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 108.54 128.80 118.36 140.20 143.33

Competitive Comparison of Wuhan Keqian Biology Co's Days Sales Outstanding

For the Biotechnology subindustry, Wuhan Keqian Biology Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuhan Keqian Biology Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Wuhan Keqian Biology Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Wuhan Keqian Biology Co's Days Sales Outstanding falls into.



Wuhan Keqian Biology Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Wuhan Keqian Biology Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (323.708 + 331.412) / 2 ) / 1064.075*365
=327.56 / 1064.075*365
=112.36

Wuhan Keqian Biology Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (331.412 + 312.354) / 2 ) / 204.929*365 / 4
=321.883 / 204.929*365 / 4
=143.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wuhan Keqian Biology Co  (SHSE:688526) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Wuhan Keqian Biology Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Wuhan Keqian Biology Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan Keqian Biology Co (SHSE:688526) Business Description

Traded in Other Exchanges
N/A
Address
No. 419, Gaoxin 2nd Road, Donghu New Technology Development Zone, Hubei Province, Wuhan, CHN, 430073
Wuhan Keqian Biology Co Ltd is engaged in research and development, production, sales and animal epidemic prevention technical services of veterinary biological products. The company's products include Combination plan; Vaccine for swine; Poultry vaccine; Pet vaccine; and Diagnostic reagent.
Executives
Hao Gen Xi Core technical personnel
Zhang Hua Wei Core technical personnel
Zhou Ming Guang Core technical personnel
Zou Tian Tian senior management
Xu Gao Yuan Director
Chen Guan Ping Director

Wuhan Keqian Biology Co (SHSE:688526) Headlines

No Headlines